Stony Brook team has breakthrough in 'triple-negative' breast cancer research
Medical scientists have discovered a gene underlying one of the most lethal forms of breast cancer, and at the same time are proposing a way to block its activity, paving the way to successful treatment for a type of cancer that is tough to treat.
Lori Chan and her team at Stony Brook University have been studying a form of breast cancer known as “triple negative,” a designation that means three key markers are missing on tumor cells. These markers are the targets of medications that are used to successfully treat other forms of the disease, boosting patients' survival.
Read the full article HERE